Nexus 2021 Day Two Recap: Empowering Data-Driven Science with Flexible Informatics Day Two of Revvity Signal's Nexus 2021 Informatics Virtual User Conference delivered another engaging slate of presenters – from Merck KGaA, Birla Carbon and Givaudan to Bayer, Nimbus Therapeutics and Johnson & Johnson. If you’ve registered but missed a session (or even a day...
Data and Process Driven R&D Organizations Need to Transform
When analyzing data there is often a competition between getting an analysis set up just the way you want versus implementing a consistent method across your data and organization. Often with flexible tools, it is easy to adjust the analysis, but difficult to use it repeatedly at scale. Whereas with scalable tools, once a system is setup, the difficulty of...
Nexus 2021 – Revvity Signals Virtual User Conference – kicked off today with an exciting schedule of keynotes, technology innovation spotlights, and industry case studies from companies including Merck, Janssen, Roche Diagnostics, Bayer, Gilead Science, Bristol Meyer Squibb, and more.
Creating data is easy. The rapid analysis and use of that data, however, is orders of magnitude more difficult. Biopharma companies are under pressure from all sides to leverage the power of data analytics. Financial stakeholders expect a timely return on their investment. Regulators are closely scrutinizing the biopharma industry as it explores new...
Traditional approaches for making, testing and deciding which new materials need to be replaced by a holistic digital solution Materials scientists today can engineer complex nanostructures and model topologically intricate architectures with relative ease. But unlike in other fields, they can’t seem to shed antiquated workflows and outmoded data storage and...
